Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PYLARIFY® safely and effectively. See full prescribing information for PYLARIFY. PYLARIFY® (piflufolastat F 18) injection, for intravenous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
PYLARIFY is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.
- generic_name
- piflufolastat f-18
- product_names
- PIFLUFOLASTAT F-18
- ndc
- 71258-022, 71258-022-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en